(MTX) Minerals Technologies - Ratings and Ratios
Pet Litter, Calcium Carbonate, Refractory, Geosynthetics, Filtration
Dividends
| Dividend Yield | 0.73% |
| Yield on Cost 5y | 0.76% |
| Yield CAGR 5y | 19.66% |
| Payout Consistency | 95.8% |
| Payout Ratio | 7.8% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 29.0% |
| Value at Risk 5%th | 44.5% |
| Relative Tail Risk | -6.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.69 |
| Alpha | -34.81 |
| CAGR/Max DD | 0.06 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.421 |
| Beta | 0.897 |
| Beta Downside | 0.910 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.47% |
| Mean DD | 18.01% |
| Median DD | 17.59% |
Description: MTX Minerals Technologies November 12, 2025
Minerals Technologies Inc. (NYSE: MTX) manufactures mineral-based products and services across two operating segments: Consumer & Specialties and Engineered Solutions. The Consumer & Specialties segment supplies household and personal-care items-including pet litter, fabric-care additives, and edible-oil purification-under brands such as PREMIUM CHOICE, VitaLife, and ENERSOL, as well as specialty calcium-carbonate additives used in paper, packaging, automotive and construction markets. The Engineered Solutions segment focuses on high-temperature mineral blends for casting automotive and heavy-truck components, infrastructure-grade geosynthetic clay liners, waterproofing systems, green-roof products, and refractory materials (including PYROID carbon composites).
Geographically, MTX sells primarily through a direct sales force and regional distributors in North America, Latin America, Europe, Africa and Asia. The company reported FY 2023 revenue of roughly $1.4 billion, with an adjusted EBITDA margin of about 13 % and free cash flow of $120 million, indicating solid cash generation despite cyclical exposure to construction and automotive casting demand.
Key economic drivers for MTX include (1) the sustained shift toward sustainable and lightweight packaging, which boosts demand for calcium-carbonate additives; (2) increased infrastructure spending in the United States and Europe, supporting the engineered-solutions line of geosynthetic liners and refractory products; and (3) the automotive industry’s transition to higher-temperature alloys, which raises the premium for custom mineral blends used in casting. A potential downside is the sensitivity of the engineered-solutions segment to macro-economic slowdowns in heavy-truck and construction equipment production.
Given the mix of defensive specialty-chemical exposure and growth tied to infrastructure and sustainability trends, MTX warrants a closer quantitative assessment; a good next step is to review ValueRay’s detailed valuation models for the stock.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (-1.60m TTM) > 0 and > 6% of Revenue (6% = 124.3m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -2.42pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 28.09% (prev 31.85%; Δ -3.76pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 199.8m > Net Income -1.60m (YES >=105%, WARN >=100%) |
| Net Debt (658.1m) to EBITDA (169.8m) ratio: 3.88 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.98 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (31.3m) change vs 12m ago -3.10% (target <= -2.0% for YES) |
| Gross Margin 25.41% (prev 25.43%; Δ -0.02pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 60.45% (prev 62.61%; Δ -2.16pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.18 (EBITDA TTM 169.8m / Interest Expense TTM 56.0m) >= 6 (WARN >= 3) |
Altman Z'' 4.80
| (A) 0.17 = (Total Current Assets 1.17b - Total Current Liabilities 591.5m) / Total Assets 3.46b |
| (B) 0.71 = Retained Earnings (Balance) 2.45b / Total Assets 3.46b |
| (C) 0.02 = EBIT TTM 65.9m / Avg Total Assets 3.43b |
| (D) 1.20 = Book Value of Equity 2.10b / Total Liabilities 1.75b |
| Total Rating: 4.80 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 47.74
| 1. Piotroski 3.50pt |
| 2. FCF Yield 3.91% |
| 3. FCF Margin 4.68% |
| 4. Debt/Equity 0.58 |
| 5. Debt/Ebitda 3.88 |
| 6. ROIC - WACC (= -4.55)% |
| 7. RoE -0.10% |
| 8. Rev. Trend 3.04% |
| 9. EPS Trend 34.74% |
What is the price of MTX shares?
Over the past week, the price has changed by +4.68%, over one month by +9.20%, over three months by -2.35% and over the past year by -21.49%.
Is MTX a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the MTX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 81.8 | 32% |
| Analysts Target Price | 81.8 | 32% |
| ValueRay Target Price | 60.9 | -1.6% |
MTX Fundamental Data Overview December 03, 2025
P/E Forward = 9.1491
P/S = 0.8839
P/B = 1.09
P/EG = 2.2637
Beta = 1.275
Revenue TTM = 2.07b USD
EBIT TTM = 65.9m USD
EBITDA TTM = 169.8m USD
Long Term Debt = 957.8m USD (from longTermDebt, last quarter)
Short Term Debt = 19.9m USD (from shortTermDebt, last quarter)
Debt = 977.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 658.1m USD (from netDebt column, last quarter)
Enterprise Value = 2.48b USD (1.83b + Debt 977.7m - CCE 328.3m)
Interest Coverage Ratio = 1.18 (Ebit TTM 65.9m / Interest Expense TTM 56.0m)
FCF Yield = 3.91% (FCF TTM 97.0m / Enterprise Value 2.48b)
FCF Margin = 4.68% (FCF TTM 97.0m / Revenue TTM 2.07b)
Net Margin = -0.08% (Net Income TTM -1.60m / Revenue TTM 2.07b)
Gross Margin = 25.41% ((Revenue TTM 2.07b - Cost of Revenue TTM 1.54b) / Revenue TTM)
Gross Margin QoQ = 25.73% (prev 25.88%)
Tobins Q-Ratio = 0.72 (Enterprise Value 2.48b / Total Assets 3.46b)
Interest Expense / Debt = 1.41% (Interest Expense 13.8m / Debt 977.7m)
Taxrate = 23.40% (13.5m / 57.7m)
NOPAT = 50.5m (EBIT 65.9m * (1 - 23.40%))
Current Ratio = 1.98 (Total Current Assets 1.17b / Total Current Liabilities 591.5m)
Debt / Equity = 0.58 (Debt 977.7m / totalStockholderEquity, last quarter 1.68b)
Debt / EBITDA = 3.88 (Net Debt 658.1m / EBITDA 169.8m)
Debt / FCF = 6.78 (Net Debt 658.1m / FCF TTM 97.0m)
Total Stockholder Equity = 1.67b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.05% (Net Income -1.60m / Total Assets 3.46b)
RoE = -0.10% (Net Income TTM -1.60m / Total Stockholder Equity 1.67b)
RoCE = 2.51% (EBIT 65.9m / Capital Employed (Equity 1.67b + L.T.Debt 957.8m))
RoIC = 1.91% (NOPAT 50.5m / Invested Capital 2.65b)
WACC = 6.45% (E(1.83b)/V(2.81b) * Re(9.32%) + D(977.7m)/V(2.81b) * Rd(1.41%) * (1-Tc(0.23)))
Discount Rate = 9.32% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.86%
[DCF Debug] Terminal Value 72.75% ; FCFE base≈129.2m ; Y1≈121.9m ; Y5≈115.2m
Fair Price DCF = 53.11 (DCF Value 1.65b / Shares Outstanding 31.1m; 5y FCF grow -7.24% → 3.0% )
EPS Correlation: 34.74 | EPS CAGR: 5.90% | SUE: 1.02 | # QB: 2
Revenue Correlation: 3.04 | Revenue CAGR: 2.98% | SUE: 0.43 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.36 | Chg30d=-0.130 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=6.19 | Chg30d=-0.080 | Revisions Net=-2 | Growth EPS=+12.3% | Growth Revenue=+4.0%
Additional Sources for MTX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle